A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles

被引:54
作者
Tao, Wanyin [1 ]
Xu, Chunliang [1 ]
Ding, Qiang [1 ]
Li, Rui [1 ]
Xiang, Yu [1 ]
Chung, Josan [2 ]
Zhong, Jin [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
基金
中国国家自然科学基金;
关键词
Hepatitis C virus; E2; glycoprotein; Infectivity; Lipoprotein; B TYPE-I; HIGH-DENSITY-LIPOPROTEINS; SCAVENGER RECEPTOR BI; HUMAN HEPATOCYTES; CELL-CULTURE; NEUTRALIZING ANTIBODIES; STRUCTURAL PROTEINS; VERY-LOW; ENTRY; CD81;
D O I
10.1016/j.virol.2009.09.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) infection is a major worldwide health problem. Our previous results showed that HCV evolved to gain the enhanced infectivity and altered buoyant density distribution during persistent infections in vitro. Here we showed that a point mutation I414T in HCV E2 was mainly responsible for these phenotypic changes. While the I414T mutation had no significant effect on HCV RNA replication and viral entry, it enhanced the production of infectious viral particles and decreased the dependency of viral entry on the levels of HCV receptors. Furthermore, we showed that the I414T mutation reduced the association of viral particles with low-density lipoprotein or very low-density lipoproteins during the virus secretion process, and the infection of the delipidated virus was more sensitive to the blockade by an anti-E2 neutralizing antibody and recombinant CD81 proteins. Our results provided more insights into understanding the roles of lipoprotein associations in HCV life cycle. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 76
页数:10
相关论文
共 50 条
[31]   Isolation of Human Monoclonal Antibodies to the Envelope E2 Protein of Hepatitis C Virus and Their Characterization [J].
Shimizu, Yohko K. ;
Hijikata, Minako ;
Oshima, Masamichi ;
Shimizu, Kazufumi ;
Alter, Harvey J. ;
Purcell, Robert H. ;
Yoshikura, Hiroshi ;
Hotta, Hak .
PLOS ONE, 2013, 8 (02)
[32]   Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference [J].
Sautto, Giuseppe ;
Mancini, Nicasio ;
Diotti, Roberta A. ;
Solforosi, Laura ;
Clementi, Massimo ;
Burioni, Roberto .
ANTIVIRAL RESEARCH, 2012, 96 (01) :82-89
[33]   Structural properties of the ectodomain of hepatitis C virus E2 envelope protein [J].
Rodriguez-Rodriguez, Mar ;
Tello, Daniel ;
Yelamos, Belen ;
Gomez-Gutierrez, Julian ;
Pacheco, Beatriz ;
Ortega, Sara ;
Serrano, Alicia G. ;
Peterson, Darrell L. ;
Gavilanes, Francisco .
VIRUS RESEARCH, 2009, 139 (01) :91-99
[34]   Characterisation of bacterially expressed structural protein E2 of hepatitis C virus [J].
Yurkova, MS ;
Patel, AH ;
Fedorov, AN .
PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) :119-125
[35]   Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a [J].
Jung, Bo-Kyoung ;
Kim, Hye-Ran ;
Park, Gyu-Nam ;
Luo, Guangxiang ;
Chang, Kyung-Soo .
JOURNAL OF MICROBIOLOGY, 2016, 54 (06) :451-458
[36]   Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs [J].
McGregor, Joey ;
Hardy, Joshua M. ;
Lay, Chan-Sien ;
Boo, Irene ;
Piontek, Michael ;
Suckow, Manfred ;
Coulibaly, Fasseli ;
Poumbourios, Pantelis ;
Center, Rob J. ;
Drummer, Heidi E. .
JOURNAL OF VIROLOGY, 2022, 96 (05)
[37]   Characterization of Hepatitis C Virus Recombinants with Chimeric E1/E2 Envelope Proteins and Identification of Single Amino Acids in the E2 Stem Region Important for Entry [J].
Carlsen, Thomas H. R. ;
Scheel, Troels K. H. ;
Ramirez, Santseharay ;
Foung, Steven K. H. ;
Bukh, Jens .
JOURNAL OF VIROLOGY, 2013, 87 (03) :1385-1399
[38]   Murine antibody against E2 can capture hepatitis C virus in vitro [J].
Ma, WB ;
Feng, BF ;
Tao, QM .
CHINESE MEDICAL JOURNAL, 2001, 114 (08) :860-863
[39]   Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages [J].
Kwon, Young-Chan ;
Meyer, Keith ;
Peng, Guangyong ;
Chatterjee, Soumya ;
Hoft, Daniel F. ;
Ray, Ranjit .
HEPATOLOGY, 2019, 69 (05) :1873-1884
[40]   Variations within hepatitis C virus E2 protein and response to interferon treatment [J].
Lo, SY ;
Lin, HH .
VIRUS RESEARCH, 2001, 75 (02) :107-112